EP0444000A3
Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
Abstract
The present invention relates to storage-stable glucosamine sulphate oral dosage forms including calcium carbonate and ascorbic acid. The invention also relates to the methods of production of these oral dosage forms.
Term
Term ended
Projected expiry passed 12 February 2011, 15.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0178602A2 | Cites | European Patent Office (EPO) | YD | Search report |
| EP0214642A2 | Cites | European Patent Office (EPO) | AD | Search report |
| EP0264259A1 | Cites | European Patent Office (EPO) | A | Search report |
| US4642237A | Cites | United States of America | Y | Search report |
10 members in 5 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 483572 | United States of America | – | |
| 48357290 | United States of America | A | |
| US19900483572 | – | – | – |
Members10
| Document | Office | Kind | |
|---|---|---|---|
| CA2035841A1 | Canada | A1 | |
| EP0444000A2 | European Patent Office (EPO) | A2 | |
| EP0444000A3This record | European Patent Office (EPO) | A3 | |
| EP0444000B1 | European Patent Office (EPO) | B1 | |
| AT99946T | Austria | T | |
| DE69100954D1 | Germany | D1 | |
| JPH0687762A | Japan | A | |
| DE69100954T2 | Germany | T2 | |
| CA2035841C | Canada | C | |
| JP3135273B2 | Japan | B2 |
36 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation not filedEN | EN | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0444000
- Publication, DOCDB
- 0444000
- Publication, EPODOC
- EP0444000
- Application
- 850031
- Application, DOCDB
- 91850031
- Application, EPODOC
- EP19910850031
Titles3
- English
- Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
- German
- Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung
- French
- Formes de doses orales du sulfate de la glucosamine stables au stockage et leurs procédés de préparation
Classification
- CPC, 9
- A61K31/7004
- A61K9/2009
- A61K9/2013
- A61K47/02
- A61K47/22
- C07H5/06
- A61P3/00
- A61P19/02
- A61P29/00
- IPC, 11
- A61K9 14
- A61K9 20
- A61K9 48
- A61K31 70
- A61K31 7008
- A61K47 02
- A61K47 22
- A61P3 00
- A61P19 02
- A61P29 00
- C07H5 06
Designated states14
- Contracting states, 14
- Austria
- Belgium
- Switzerland
- Germany
- Denmark
- Spain
- France
- United Kingdom
- Greece
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden